Completeness of hepatitis, brucellosis, syphilis, measles and HIV/AIDS surveillance in Izmir, Turkey

Durusoy, Raika; Karababa, Ali O.
January 2010
BMC Public Health;2010, Vol. 10 Issue 1, p71
Academic Journal
Background: According to the surveillance system in Turkey, most diseases are notified only by clinicians, without involving laboratory notification. It is assumed that a considerable inadequacy in notifications exists; however, this has not been quantified by any researcher. Our aim was to evaluate the completeness of communicable disease surveillance in the province of Izmir, Turkey for the year of 2003 by means of estimating the incidences of diseases. Methods: Data on positive laboratory results for the notifiable and serologically detectable diseases hepatitis A, B, C, brucellosis, syphilis, measles and HIV detected in 2003 in Izmir (population 3.5 million) were collected from serology laboratories according to WHO surveillance standards and compared to the notifications received by the Provincial Health Directorate. Data were checked for duplicates and matched. Incidences were estimated with the capture-recapture method. Sensitivities of both notifications and laboratory data were calculated according to these estimates. Results: Among laboratories performing serologic tests (n = 158) in Izmir, 84.2% accepted to participate, from which 23,515 positive results were collected. Following the elimination of duplicate results as well as of cases residing outside of Izmir, the total number was 11,402. The total number of notifications was 1802. Notification rates of cases found in laboratories were 31.6% for hepatitis A, 12.1% for acute hepatitis B, 31.8% for brucellosis, 25.9% for syphilis and 100% for HIV confirmation. Conclusions: It was discovered that for hepatitis A, B, C, brucellosis and syphilis, there is a considerable undernotification by clinicians and that laboratory data has the potential of contributing greatly to their surveillance. The inclusion of laboratories in the surveillance system of these diseases could help to achieve completeness of reporting.


Related Articles

  • Impact of human immunodeficiency virus (HIV) infection on the progression of liver fibrosis in hepatitis C virus infected patients. Mohsen, A.H.; Easterbrook, P.J.; Taylor, C.; Portmann, B.; Kulasegaram, R.; Murad, S.; Wiselka, M.; Norris, S. // Gut;Jul2003, Vol. 52 Issue 7, p1035 

    Objectives: To compare the rate of hepatic fibrosis progression in hepatitis C virus (HCV) infected and human immunodeficiency virus (HIV)-HCV coinfected patients, and to identify factors that may influence fibrosis progression. Patients and methods: A total of 153 HCV infected and 55 HCV-HIV...

  • Progression of Chronic Hepatitis C to Liver Fibrosis and Cirrhosis in Patients Coinfected with Hepatitis C Virus and Human Immunodeficiency Virus. Martinez-Sierra, Carmen; Arizcorreta, Ana; Díaz, Fernando; Roldán, Rafael; Martín-Herrera, Leopoldo; Pérez-Guzmán, Eugenio; Girón-González, José A. // Clinical Infectious Diseases;2/15/2003, Vol. 36 Issue 4, p491 

    To evaluate the factors associated with the evolution of chronic hepatitis C in human immunodeficiency virus (HIV)-infected patients, a cross-sectional analysis of 41 HIV-infected patients with chronic hepatitis C (known as "HIV-HCV [hepatitis C virus]-coinfected patients") and a control group...

  • Deaths from hepatitis C overtake deaths from HIV in the US.  // BMJ: British Medical Journal (Overseas & Retired Doctors Edition;3/3/2012, Vol. 344 Issue 7846, p12 

    The article reports that there are more individuals who died from hepatitis C (15, 106) in the U.S. in 2007 than those who died from HIV (12, 734) based on the analysis of U.S. death certificates.

  • Lamivudine/abacavir.  // Reactions Weekly;Nov2014, Vol. 1527 Issue 1, p132 

    The article presents the case of a 57-year-old man, who developed HIV encephalopathy due to the development of lamivudine/abacavir resistance while getting treatment for HIV infection.

  • Understanding Hepatitis and HIV Co-Infection. Anderson, Tomika // Washington Informer;9/15/2011, Vol. 46 Issue 97, p20 

    The article discusses the co-infection of hepatitis and HIV.

  • Occurrence of Acute Hepatitis A in Patients Infected with Human Immunodeficiency Virus. Fonquernie, L.; Meynard, J. L.; Meyohas, M. C.; Frottier, J.; Charrois, A.; Delamare, C. // Clinical Infectious Diseases;1/15/2001, Vol. 32 Issue 2, p297 

    Focuses on a study which examined the prevalence of acute hepatitis A in HIV-infected patients. Description of the subjects of the study; Diagnosis of hepatitis A; Risk factors of hepatitis A.

  • GADVASU gets international patent for diagnostic test.  // BioSpectrum;Jun2013, Vol. 11 Issue 6, p84 

    The article reports that Guru Angad Dev Veterinary and Animal Sciences University's (GADVASU) South African patent on the diagnosis of infectious diseases such as brucellosis, salmonellosis, and HIV infection, was granted.

  • A survey of community pharmacists on prevention of HIV and hepatitis B and C: current practice and attitudes in Grampian. L. Watson; C. Bond; C. Gault // Journal of Public Health Medicine;Mar2003, Vol. 25 Issue 1, p13 

    Background Prevention of infection with the blood-borne pathogens (BBPs) HIV and hepatitis B and C remains a major public health challenge. The aim of this study was to assess the activity, knowledge and attitudes of community pharmacists in Grampian in prevention of HIV and hepatitis B and C....

  • SAFETY IN HANDLING OF CADAVERS. JAYAKUMAR, KARTHIKA; JOTHI, SWAYUM // International Journal of Medical & Clinical Research;2012, Vol. 3 Issue 3, p140 

    Aim: To know the presence/ absence of infectious agents like: Bacterial Causes: Tuberculosis, Gram positive & Gram negative organisms. Viral Causes: HEPATITIS B&C; HIV in cadavers. Materials & Methods: Samples were collected from 6 medical colleges in and around Tamil Nadu& Andhra Pradesh. A...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics